Nantahala Capital Management’s TELA Bio TELA Stock Holding History
Bought
Maintained
Sold
Other funds holding TELA
EWM
SCM
SCM
VCM
DCM
PCM
SCM
Nantahala Capital Management's TELA Position: Q1 2026 in Review
Nantahala Capital Management increased its TELA Bio (TELA) stake by 0.64% in Q1 2026, buying an estimated $28.2K and bringing the position to 5,144,114 shares worth $3.19M. The position accounts for 0.12% of the portfolio, ranked #117.
Nantahala Capital Management first reported a position in TELA in Q3 2022 and has held it in 15 quarters since. The position peaked at $11.5M in Q2 2024. 36 funds tracked by Wall St. Rank hold TELA as of Q1 2026.
- Nantahala Capital Management held 5,144,114 shares of TELA Bio worth $3.19M as of Q1 2026.
- Nantahala Capital Management bought 32,526 TELA Bio shares in Q1 2026, an estimated $28.2K.
- TELA Bio made up 0.12% of Nantahala Capital Management's portfolio in Q1 2026, its #117 holding.
- Nantahala Capital Management first reported a position in TELA Bio in Q3 2022 and has held it in 15 quarters since.
- Nantahala Capital Management's TELA Bio position peaked at $11.5M in Q2 2024.
- 36 funds tracked by Wall St. Rank held TELA Bio as of Q1 2026.
Based on Nantahala Capital Management's 13F filing for Q1 2026, filed 15 May 2026.